B9402033 陳長聖.  local control without sacrificing joint function.  intralesional curettage  With autograft reconstruction  With cementing  Sometime.

Slides:

Advertisements

Similar presentations

Yoshiya Yamada M.D., Ilya Laufer M.D., Brett W. Cox M.D.,

Advertisements

Prof Dr Harzem Ozger Istanbul University Istanbul Faculty of Medicine Dept. Of Orthopaedics and Traumatology Orthopedic Oncologic Approach in Sacrum Tumors.

The Challenge of Prostate Cancer Genitourinary Cancer Center at M. D. Anderson PERSONALIZED MEDICINE.

PREOPERATIVE TRANSARTERIAL EMBOLISATION (TAE) OF SPINAL TUMOURS ID NO : IRIA

Breast cancer surgery Breast preserving and oncoplastic surgery (2)

Hemicortical Resection and Inlay Allograft Reconstruction for Primary Bone Tumors by M.P.A. Bus, J.A.M. Bramer, G.R. Schaap, H.W.B. Schreuder, P.C. Jutte,

Total en bloc Spondylectomy If not for primary malignant tumors, for what else then? Sohail Bajammal, MBChB, MSc, FRCS(C) October 29, 2008.

Tissue Engineering By: Cassie Kuchta & Tim Rohman.

Maša Radeljak Mentor: A. Žmegač Horvat

Thomas F. DeLaney MD, Aashish D. Bhatt MD, Alex Jacobson BS, Richard Y. Lee MD, PhD, Christine Giraud BS, Joseph H. Schwab MD, MS, Francis J. Hornicek.

GISTs- Gastrointestinal Stromal Tumor

SURGEONS ROLE AND INVOLVEMENT IN SBRT PROGRAM Stephen R. Hazelrigg, M.D. Professor and Chair, Cardiothoracic Surgery Southern Illinois University, School.

TUMOURS OF NASAL CAVITY & PARANASAL SINUSES

Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. Chapter 100 Basic Principles of Cancer Chemotherapy.

Mitosis & Cancer: When Making New Cells Goes Terribly Wrong!

GIANT CELL TUMOR OF BONE IN PAEDIATRIC PATIENT. Presentation  17 years old (currently) female with significant right shoulder pain and rihgt upper extremity.

Placenta Site Trophoblastic Tumor (PSTT) dr yousefi Gynecologist oncologist of Medical Sciences of Mashhad University.

 General recommendations -adjuvant systemic therapy :with tamoxifen or multiple-chemotherapy agent :lower the incidence of recurrence by about 30% - in.

Management of DCIS KWH Experience Dr. Carmen Ho.

Metastatic Mixed Tumor Arising in Bone by Richard L. McGough, Li Juan Wang, Douglas R. Gnepp, and Richard M. Terek J Bone Joint Surg Am Volume 83(9):

Case Presentation 성균관의대 삼성서울병원 정형외과 성기선 증례 11. F/

Ostoesarcoma By: Tori Hagel. Osteosarcoma  A malignant tumor of bone in which there is a proliferation of osteoblast.  A type of bone cancer.

Bulk Structural Autogenous Grafts and Allografts for Reconstruction of the Acetabulum in Total Hip Arthroplasty. Sixteen-Year-Average Follow-up* by ANDREW.

RECURRENT GIANT CELL TUMOR March 18, 2010 By: Chris Beauchamp MyPACS Case # 3742.

BONE TUMORS Pamela Gregory-Fernandez RPA-C. Benign Primary Bone Tumors Definition = tumors that arise from cells of mesenchymal origin –Bone; cartilage;

$100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300.

Solving Systems of Equations by Elimination (Addition)

Bone Prepared by Dr.Salah Mohammad Fateh MBChB,DMRD,FIBMS(radiology) Lecture no. 1.

Surgical Management of Metastatic Bone Disease by Jacob Bickels, Shlomo Dadia, and Zvi Lidar J Bone Joint Surg Am Volume 91(6): June 1, 2009 ©2009.

Cell Processes & Energy Cancer Chapter 2 Section 4.

By: Gisselle Beltran, Christopher Sanchez, Kimberly Rojas, Karime Lagarda.

Management of Capsular Deficiency of the Shoulder by Jon J.P. Warner, Andreas A. Venegas, Janne T. Lehtinen, and John J. Macy J Bone Joint Surg Am Volume.

Non-ossifying fibroma (fibrous cortical defect). Lucent fibrous tissue lesion (benign) inside bone cortex. Mostly accidentally discovered by x- ray. Seen.

Time Remaining 20:00.

Treatment. Medical Care Radiotherapy Stereotactic Radiosurgery Surgical Care.

BREAST CANCER Vanessa Parra Rosina Baltazar Rosio Parra Cancer that starts in the tissue of the Breast (2 types): -Ductal carcinoma -Lobular carcinoma.

Bone tumors More than 80% of bone tumors are either secondary or its multiple myaloma, and primary bone tumors accounts for less than 20% of all bone tumors.

Cytotoxic Effect of Zoledronic Acid-Loaded Bone Cement on Giant Cell Tumor, Multiple Myeloma, and Renal Cell Carcinoma Cell Lines by Pawel Zwolak, J. Carlos.

BASIS OF CANCER CHEMOTHERAPY PHL 417 Dr. Mohamed M. Sayed-Ahmed.

Improved Prognosis for Patients with Ewing Sarcoma in the Sacrum Compared with the Innominate Bones by Asle Charles Hesla, Panagiotis Tsagozis, Nina Jebsen,

Cancer cells grow and divide out of control Ch. 9.4.

Disappearance of a Cervical Spine Chordoma After Nonoperative Treatment by Roman Radl, Andreas Leithner, Norbert Kastner, Koppany Bodo, Alexander Nader,

Tumor markers 1111.

Cancer Chemotherapy.

Desmoplastic small round cell tumor

Bone tumours 2.

Dr Amit Gupta Associate Professor Dept Of Surgery

Tenosynovial giant cell tumor Left low power view shows a lobulated tumor mass with lobules divided by thick collagen fibers (left, low-power view). High.

Bone tumors Primary: Secondary- COMMON Lesions similar to tumors

RADIOLOGY BONE DISEASE

Tyler Hoskins, B.S.1, Laura Sonnylal, B.S.1, James C. Wittig, M.D. 1

Limb salvage (saving) surgery for malignant bone tumors of limbs

RADIOLOGY BONE DISEASE

New Views into the Prostate Cancer Genome

Basic Principles of Cancer Chemotherapy

MSK system- 2nd yr medical students

Why Treat Seborrheic Keratosis?

Glioma, Chondroblastoma and Giant Cell Tumour of Bone Share Mutations

Allison Hanlon, MD, PhD, June Kim, MD, David J. Leffell, MD

Sarcoma Wound Complications

A Glomus Tumor With Recurrence and Malignant Transformation in the Chest Wall: A Cautionary Tale of Seeding? Ivan H.W. Yim, MRCS, Malcolm B. Will, PhD,

C11 Breast cancer Treatments

1. Identify the tissue.

Name that bone....

Primary Giant Clear Cell Sarcoma (Soft Tissue Malignant Melanoma) of the Sternum Gaetano Rocco, MD, FRCS(Ed), Anna Rosaria de Chiara, MD, Flavio Fazioli,

Fig. 2. One case of recurrence out of 12 adult patients with totally resected ependymomas without anaplastic pathology or postoperative adjuvant treatment.

Prognosis of angiosarcoma at different anatomic sites

Fig. 5. Serial follow-up sellar MRIs after treatment

MSK system- 2nd yr medical students

Presentation transcript:

B 陳長聖

 local control without sacrificing joint function.  intralesional curettage  With autograft reconstruction  With cementing  Sometime with adjuvant

With Autograft 1. reconstruction is permanent 1. Autograft quantity limited 2. Allograft expensive 3. Recurrence difficult to spot With Cementing 1. detection of recurrence is easier 2. Immediate structural support 1. Not a biological material 2. long-term degeneration

 may be of additional benefit in helping to decrease recurrence rates  methylmethacrylate  local hyperthermia  necrosis of any remaining neoplastic tissue

 for lesions of the spine and sacrum or for aggressive, multiply recurrent tumors  radiotherapy  no recognized effective chemotherapeutic agents available  surgery remains the treatment of choice

 Puri A, Agarwal M. Treatment of giant cell tumor of bone: Current concepts. Indian J Orthop [serial online] 2007 [cited 2009 Apr 18];41: Available from: 7/41/2/101/32039http:// 7/41/2/101/32039